Our data further reveal that the Wnt and mTOR pathways downstream of Akt show different responses to ADAM9 knockdown (KD) in different CRC cell lines, likely due to the presence of different mutations in these cells. This evidence concerns the gene ADAM9 and colorectal carcinoma.